Romosozumab in severe postmenopausal osteoporosis—real-world data from 192 women

Nicolas Dehne, Felix N. von Brackel, Claudia Günzl, Florian Barvencik, Ralf Oheim

Open source

DOI
10.1007/s00198-026-08127-x
Published
2026-07-08
Container
Osteoporosis International
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00198-026-08127-x,
  title = {Romosozumab in severe postmenopausal osteoporosis—real-world data from 192 women},
  author = {Nicolas Dehne and Felix N. von Brackel and Claudia Günzl and Florian Barvencik and Ralf Oheim},
  year = {2026},
  journal = {Osteoporosis International},
  doi = {10.1007/s00198-026-08127-x},
  url = {https://doi.org/10.1007/s00198-026-08127-x}
}

RIS

TY  - JOUR
TI  - Romosozumab in severe postmenopausal osteoporosis—real-world data from 192 women
AU  - Nicolas Dehne
AU  - Felix N. von Brackel
AU  - Claudia Günzl
AU  - Florian Barvencik
AU  - Ralf Oheim
PY  - 2026
JO  - Osteoporosis International
DO  - 10.1007/s00198-026-08127-x
UR  - https://doi.org/10.1007/s00198-026-08127-x
ER  - 

APA

Dehne, N., Brackel, F. N. V., Günzl, C., Barvencik, F., & Oheim, R. (2026). Romosozumab in severe postmenopausal osteoporosis—real-world data from 192 women. Osteoporosis International. https://doi.org/10.1007/s00198-026-08127-x

Source records